Evaluation of Vastus Medialis Muscle Inhibition in Indoor Soccer Players With and Without ACL Injury
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-45
SponsorUniversity of Alcala
About this trial
The Anterior Cruciate Ligament (ACL) is vital for knee stability, and ACL injuries in futsal can lead to long-term issues. Reconstruction surgery may be affected by Anthrogenic Muscle Inhibition (AMI), especially in the vastus medialis muscle. This study aims to compare AMI in futsal players with ACL injuries to those without injuries, focusing on measurement techniques, sports performance, muscle strength, and recovery time. The research involves evaluating 54 players (27 injured and 27 non-injured) at various stages of the season using strength tests and imaging.
Eligibility criteria
Qualifiers
Age between 18 and 45 years old
Playing in the Spanish National League (first or second category) or in the Madrid Futsal Federation in PRIMERA RFFM and PREFERENTE.
Both sexes
Have been playing futsal for at least 2 years
Disqualifiers
Operations other than an Anterior Cruciate Ligament injury (Cartilage, Meniscus, Ligaments).
Injuries to the knee of the contralateral lower limb. (sprains, fracture)
Muscle injuries or conditions in the affected or contralateral limb for less than 2 months (sprains, tibial periostitis, tendinopathies, tears).
Any infection must be reported after the intervention and will be excluded from the study.
Trial design
Treatments tested in this trial
- Anthrogenic Muscle Inhibition (AMI) Assessment Protocol
Treatment groups
64 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov